Cwm, LLC Akero Therapeutics, Inc. Transaction History
Cwm, LLC
- $24.1 Billion
- Q4 2024
A detailed history of Cwm, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 135 shares of AKRO stock, worth $7,269. This represents 0.0% of its overall portfolio holdings.
Number of Shares
135
Previous 120
12.5%
Holding current value
$7,269
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AKRO
# of Institutions
190Shares Held
74.6MCall Options Held
241KPut Options Held
647K-
Wellington Management Group LLP Boston, MA7.9MShares$425 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X07.08MShares$381 Million0.11% of portfolio
-
Rtw Investments, LP New York, NY5.92MShares$319 Million2.71% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$301 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$282 Million4.29% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.5B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...